Cargando…
Eg5 inhibitor YL001 induces mitotic arrest and inhibits tumor proliferation
Eg5 is a kinesin spindle protein that controls chromosomal segregation in mitosis and is thus a critical drug target for cancer therapy. We report the discovery of a potent, selective inhibitor of Eg5 designated YL001. YL001 was obtained through shape similarity based virtual screening, and it bears...
Autores principales: | Wang, Yufei, Wu, Xingyu, Du, Mufeng, Chen, Xi, Ning, Xianling, Chen, Hong, Wang, Siyuan, Liu, Jia, Liu, Zhenming, Li, Ridong, Fu, Ge, Wang, Chunguang, McNutt, Michael A., Zhou, Demin, Yin, Yuxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522084/ https://www.ncbi.nlm.nih.gov/pubmed/28489567 http://dx.doi.org/10.18632/oncotarget.17207 |
Ejemplares similares
-
Protein Phosphatase 2A (PP2A) Regulates EG5 to Control Mitotic Progression
por: Liu, Yang, et al.
Publicado: (2017) -
Synthesis and antitumor activity of novel 2, 3-didithiocarbamate substituted naphthoquinones as inhibitors of pyruvate kinase M2 isoform
por: Ning, Xianling, et al.
Publicado: (2017) -
Non‐canonical functions of the mitotic kinesin Eg5
por: Liu, Min, et al.
Publicado: (2018) -
HSP70 regulates Eg5 distribution within the mitotic spindle and modulates the cytotoxicity of Eg5 inhibitors
por: Fang, Chieh-Ting, et al.
Publicado: (2020) -
Impaired angiogenesis and tumor development by inhibition of the mitotic kinesin Eg5
por: Exertier, Prisca, et al.
Publicado: (2013)